The CD44+ PCa cell population acutely purified from xenograft models possesses high metastatic potential13, 20, 25; thus, we determined whether manipulating miR-141 levels in CD44+ or bulk PCa cells would affect their metastatic capabilities. The gene discussed is CD44; the disease is posterior cortical atrophy.